About
Dr. Audrey Tétreault-Laflamme, a Radiation Oncologist, utilizes advanced radiation therapies to treat various forms of cancer, working as part of a multidisciplinary team. Practicing at CHUS, Dép de Radio-Oncologie in Sherbrooke, QC, she is committed to providing comprehensive cancer care in a setting that emphasizes patient-centered treatment. Her role involves the precise planning and delivery of radiation therapy for a broad spectrum of cancer types, ensuring that each patient receives personalized, evidence-based treatment in a compassionate environment. The facility adheres to the high standards set by the Collège des médecins du Québec (CMQ), ensuring quality and safety in every aspect of care. Patients with suspected or diagnosed cancer or blood disorders benefit from access to state-of-the-art diagnostic and therapeutic resources, all within a supportive clinical setting.
Dr. Tétreault-Laflamme completed her medical degree in 2016 and has been practicing as a Radiation Oncologist for over 8 years. Her extensive post-graduate training and certification in Radiation Oncology (Cancer Treatment with Radiation) underpin her expertise in delivering precise and effective treatments. Her dedication to continuous learning and professional development ensures that she stays at the forefront of technological advances and treatment modalities in cancer care.
Her clinical philosophy emphasizes multidisciplinary collaboration, evidence-based decision-making, and compassionate support for her patients and their families. Dr. Tétreault-Laflamme is committed to personalized care that respects patient preferences and promotes optimal outcomes. Fluent in French, she communicates clearly and empathetically with her patients, ensuring they feel informed and supported throughout their treatment journey.
Dr. Audrey Tétreault-Laflamme has expertise in managing a wide range of conditions, including:
Common Cancers (Solid Tumors) Treated
- Neuroendocrine Tumors (NETs): A diverse group of tumors that arise from cells of the endocrine (hormonal) and nervous systems, treated with various systemic therapies.
- Lung Cancer (Non-Small Cell & Small Cell): Cancers originating in the lungs, treated with chemotherapy, targeted therapy, immunotherapy, and/or radiation based on type and stage.
- Breast Cancer (Early Stage, Locally Advanced, Metastatic): Malignant tumors developing in the cells of the breast, managed with various therapies including hormonal, chemo, targeted agents, and immunotherapy.
Hematologic Malignancies (Blood Cancers) Treated
- Myelodysplastic Syndromes (MDS): A group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy, mature blood cells.
- Acute Myeloid Leukemia (AML): A rapidly progressing cancer of the blood and bone marrow affecting myeloid cells.
- Non-Hodgkin Lymphoma (NHL) (e.g., Diffuse Large B-Cell, Follicular, Mantle Cell): A diverse group of blood cancers that develop from lymphocytes, with many different subtypes requiring tailored treatments.
Common Areas/Cancers Treated with Radiation Oncology
- Gynecologic Cancers (e.g., Cervical, Uterine, Vaginal, Vulvar - Radiation Aspects): Application of external beam radiation and/or brachytherapy for cancers of the female reproductive tract.
- Sarcomas (Bone & Soft Tissue - Radiation Aspects): Role of radiation therapy in the multidisciplinary management of sarcomas, often used before or after surgery.
- Thoracic Cancers (e.g., Lung Cancer, Esophageal Cancer, Mesothelioma): Using radiation therapy to treat cancers within the chest cavity, often combined with other modalities.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Audrey Tétreault-Laflamme or your referring physician.
- Image-Guided Radiation Therapy (IGRT): Utilizing advanced imaging during treatment delivery to precisely target tumors and adapt to changes, while minimizing exposure to healthy tissues.
- Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR) / Stereotactic Radiosurgery (SRS): Delivering highly focused, high-dose radiation to precisely targeted tumors or lesions in the brain or body, often in a few treatment sessions.
- Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
- Palliative Radiation Therapy for Symptom Control: Using radiation to alleviate pain, bleeding, or obstruction caused by cancer.
- Prophylactic Cranial Irradiation (PCI): Preventative radiation treatment to the brain for certain cancers at high risk of brain metastases.
- Comprehensive Oncologic & Hematologic Consultation: In-depth evaluation of medical history, review of diagnostic imaging and pathology, cancer staging (if applicable), and development of personalized treatment plans for various cancers and blood disorders.
- Radiation Therapy Consultation & Treatment Planning: Comprehensive assessment to determine if radiation therapy is an appropriate treatment modality, followed by meticulous 3D/4D simulation and treatment planning.
Note: This list provides a general overview of services offered in Radiation Oncology (Cancer Treatment with Radiation). Treatment plans are highly individualized. Dr. Tétreault-Laflamme provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Tétreault-Laflamme or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Dr. Tétreault-Laflamme practices at the CHUS, Dép de Radio-Oncologie, situated in the Fleurimont West (Hospital Area) neighborhood of Sherbrooke. The facility is conveniently accessible from Mont Bellevue Access and the Commercial Corridor North. Public transportation options are available via the Société de transport de Sherbrooke (STS), making it easy for patients to reach the center. The facility is wheelchair accessible to accommodate all patients, and metered street parking is available nearby for those arriving by car. The location is designed to provide a welcoming and accessible environment for patients seeking expert cancer treatment in Sherbrooke.
- Are consultations and treatments with Dr. Tétreault-Laflamme, an Radiation Oncologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Radiation Oncologist such as Dr. Tétreault-Laflamme are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Tétreault-Laflamme's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Tétreault-Laflamme, an Radiation Oncologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Radiation Oncologist like Dr. Tétreault-Laflamme for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- What kind of supportive care is available during cancer or hematology treatment with Dr. Tétreault-Laflamme?
- Supportive care is a crucial part of treatment, aiming to manage symptoms, reduce side effects, improve quality of life, and address emotional and practical needs. This can include effective pain and symptom management, nutritional support and counseling, psychological support (counseling, therapy), social work services for practical and emotional support, physiotherapy or occupational therapy, access to patient support groups, and spiritual care. Dr. Tétreault-Laflamme and the healthcare team at affiliated hospitals or cancer centres can connect you with these valuable resources.
- How is cancer care typically coordinated when seeing Dr. Tétreault-Laflamme?
- Cancer care and complex hematology care often involve a multidisciplinary team (MDT) of specialists working together. This team may include medical oncologists like Dr. Tétreault-Laflamme, surgeons, radiation oncologists, pathologists, radiologists, specialized oncology nurses, pharmacists, social workers, dietitians, genetic counselors, and palliative care specialists. Regular team meetings (often called tumor boards or MDT meetings) usually occur to discuss individual patient cases and develop comprehensive, coordinated treatment plans. Dr. Tétreault-Laflamme works collaboratively within this team to ensure you receive holistic and well-managed care.
CHUS, Dép de Radio-Oncologie
3001 12e Avenue N
Sherbrooke, QC J1H 5H3
Phone: (819) 346-1110
The facility is wheelchair accessible.
Dr. Tétreault-Laflamme is a licensed Radiation Oncologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=16730